Elements of Significance Testing with Equivalence Problems

Abstract

The paper outlines an approach to the general methodological problem of equivalence assessment which is based on the classical theory of testing statistical hypotheses. Within this frame of reference it is natural to search for decision rules satisfying the same criteria of optimality which are customarily applied in deriving solutions to one- and two-sided testing problems. For three standard situations very frequently encountered in medical applications of statistics, a concise account of such an optimal test for equivalence is presented. It is pointed out that tests based on the well-known principle of confidence interval inclusion are valid in the sense 1 of guaranteeing the prespecified level of significance, but tend to have an unnecessarily low efficiency.

Key-Words

Optimal Test of Equivalence - Sign Statistic - t-Statistic - Standardized Difference of Means - Noncentral F-Distribution

• REFERENCES

• 1 Westlake WJ. Use of confidence intervals in analysis of comparative bioavailability trials. J Pharm Sc 1972; 61: 1340-1.
• 2 Lehmann EL. Testing Statistical Hypotheses. 2nd Edition. New York: John Wiley & Sons; 1986
• 3 Dunnett CW, Gent M. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 x 2 tables. Biometrics 1977; 33: 593-602.
• 4 Tables of the Cumulative Bionomial Probability Distribution. Cambridge Mass: Harvard University Press; 1955
• 5 Wellek S. Vorschläge zur Reformulierung der statistischen Definition von Bioäquivalenz. In: Biometrie und Informatik – neue Wege der Erkenntnisgewinnung in del” Medizin. Repges R, Giani G. eds. Berlin: Springer-Verlag; 1990: 95-9.
• 6 Johnson NL, Kotz S. Distributions in Statistics: Continuous Univariate Distributions-2. New York: John Wiley & Sons; 1970
• 7 SAS. Language Guide for Personal Computers, Version. 6 Edition. Cary NC: SAS Institute Inc; 1986
• 8 Wellek S. Zur Formulierung und optimalen Lösung des Bioäquivalenznachweis-Problems in der klassischen Theorie des Hypothesentestens. In: Bioäquivalenz sofort Jreisetzender Arzneiformen. Mau J, Klinger H. eds. Stuttgart: G. Fischer-Verlag; (in press).
• 9 Steinijans VW, Diletti E. Statistical analysis of bioequivalence studies: Parametric and nonparametric confidence intervals. Europ J Clin Pharmacol 1983; 24: 127-36.
• 10 Steinijans VW, Diletti E. Generalisation of distribution-free confidence intervals for bioavailability ratios. Europ J Clin Pharmacol 1985; 28: 85-8.
• 11 Westlake WJ. Design and statistical evaluation of bioequivalence studies in man. In: Principles and Perspectives in Dru, Bioavailability. Blanchard J. ed. Basel: S Karger; 1979: 192-210.